XML 125 R81.htm IDEA: XBRL DOCUMENT v3.22.0.1
Schedule I Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Current assets:        
Cash and cash equivalents $ 21,375 $ 16,921 $ 10,985 $ 10,866
Total current assets 61,758 53,718    
Other assets 12,526 11,510    
Total assets 212,206 197,289 173,889  
Current liabilities:        
Accounts payable and accrued liabilities 24,643 22,495    
Short-term borrowings and current maturities of long-term debt 3,620 4,819    
Total current liabilities 78,292 72,420    
Long-term debt, less current maturities 42,383 38,648    
Other liabilities 11,787 12,315    
Total liabilities 135,727 126,750    
Commitments and contingencies (Note 4)    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding 10 10    
Additional paid-in capital 0 0    
Retained earnings 77,134 69,295    
Accumulated other comprehensive loss (5,384) (3,814)    
Total liabilities and shareholders’ equity 212,206 197,289    
Parent Company [Member]        
Current assets:        
Cash and cash equivalents 2,167 258 $ 46 $ 434
Other current assets 503 562    
Total current assets 2,670 820    
Equity in net assets of subsidiaries 116,907 107,714    
Long-term notes receivable from subsidiaries 5,680 5,021    
Other assets 32 342    
Total assets 125,289 113,897    
Current liabilities:        
Accounts payable and accrued liabilities 605 589    
Current portion of notes payable to subsidiaries 8,105 4,882    
Short-term borrowings and current maturities of long-term debt 3,009 4,465    
Total current liabilities 11,719 9,936    
Long-term debt, less current maturities 41,623 37,815    
Other liabilities 187 655    
Total liabilities 53,529 48,406    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 941 and 946 issued and outstanding 10 10    
Additional paid-in capital 0 0    
Retained earnings 77,134 69,295    
Accumulated other comprehensive loss (5,384) (3,814)    
Total UnitedHealth Group shareholders’ equity 71,760 65,491    
Total liabilities and shareholders’ equity $ 125,289 $ 113,897